Cargando…
ACE inhibitor-related angioedema in a COVID-19 patient—a plausible contribution of the viral infection?
Autores principales: | Kuzemczak, Michał, Kavvouras, Charalampos, Alkhalil, Mohammad, Osten, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779079/ https://www.ncbi.nlm.nih.gov/pubmed/33392667 http://dx.doi.org/10.1007/s00228-020-03082-w |
Ejemplares similares
-
Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit
por: Kuzemczak, Michał, et al.
Publicado: (2021) -
Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021) -
ACE Inhibitor-Induced Angioedema of the Bowel
por: Campbell, Tabitha, et al.
Publicado: (2010) -
Angioedema, ACE inhibitor and COVID-19
por: Grewal, Ekjot, et al.
Publicado: (2020) -
ACE inhibitor induced intestinal angioedema
por: Huynh, Tran Ngoc An, et al.
Publicado: (2022)